The distribution of complementary metabolic functions in hepatocytes along a portocentral axis is called liver zonation. Endothelial secreted Wnt ligands maintain metabolic zonation in the adult murine liver but whether those ligands are necessary to initiate zonation in the immature liver has been only partially explored. Also, numerous non-metabolic proteins display zonated expression in the adult liver but it is not entirely clear if their localization requires endothelial Wnts. Here we used a novel transgenic mouse model to compare the spatial distribution of zonated non-metabolic proteins with that of typical zonated metabolic enzymes during liver maturation and after acute injury induced by carbon tetrachloride (CCl 4 ). We also investigated how preventing Wnt ligand secretion from endothelial cells affects zonation patterns under homeostasis and after acute injury. Our study demonstrates that metabolic and nonmetabolic zonation are established non-synchronously during maturation and regeneration and require multiple endothelial Wnt sources.
Introduction
The liver executes multiple functions involved with anabolic and catabolic metabolism, bile and protein secretion, drug detoxification, glycogen storage, and other processes. These tasks are performed simultaneously and with maximal energy-efficiency thanks to a unique anatomical architecture consisting of hexagonal functional units (a.k.a. 'lobules'), typically arranged in a honeycomb-like pattern (Gebhardt and Matz-Soja, 2014) . At the periphery of the lobules, blood enters the portal vein and the hepatic artery and flows into the liver sinusoids towards the central vein. Inside the lobules, the highly polarized hepatocytes assemble into cords that face the hepatic sinusoids on the basolateral side and form canaliculi on the apical side (Tanaka and Miyajima, 2016) . Although morphologically quite similar, hepatocytes accomplish very different metabolic roles according to their specific position along the lobular portocentral axis. The segregation of hepatocytes into discrete functional areas is referred to as 'Liver Zonation' and is the basis for the partition of the hepatic lobule into three metabolic zones: periportal Zone 1 consisting of 6-8 hepatocyte layers that receive blood enriched in oxygen and nutrients and control glycogen metabolism, amino acid utilization and ammonia detoxification; intermediate perivenous Zone 2 consisting of 6-10 hepatocyte layers with a major role in xenobiotic metabolism; and perivenous Zone 3 formed by 2-3 hepatocyte layers that surround the central veins and perform biotransformation reactions, glutamine synthesis and glycolysis (Jungermann and Katz, 1989) . Metabolic zonation optimizes liver physiology by quickly adapting this organ to exogenous nutritional challenges and endogenous metabolic demands. Moreover, pathologic alterations that permanently change zonation patterns lead to metabolic disease (Gebhardt and Matz-Soja, 2014) .
Pioneer studies revealed that canonical Wnt/b-catenin signaling preserves metabolic zonation in the adult liver (Benhamouche et al., 2006; Burke et al., 2009; Planas-Paz et al., 2016; Sekine et al., 2006; Yang et al., 2014) and promotes the expression of pericentral enzymes involved with glutamine synthesis in the late fetal liver (Burke et al., 2018) . More recent investigations also demonstrated that Wnt ligands and the Wnt agonist R-spondin3 produced by hepatic endothelial cells are necessary to preserve metabolic zonation in the adult liver (Leibing et al., 2018; Planas-Paz et al., 2016; Preziosi et al., 2018; Rocha et al., 2015; Wang et al., 2015) . While these and other studies have increased our knowledge of adult metabolic zonation, we still do not know much about how metabolic and non-metabolic proteins begin to segregate into specific regions in the maturing liver or how zonated protein expression is reestablished in hepatocytes following acute hepatic injury. Moreover, it has been shown that hepatic sinusoidal cells produce Wnt ligands (Ding et al., 2010; Wang et al., 2015) but the potential contribution of this specialized endothelium to liver zonation recovery after acute injury has not been directly proven.
Here we used a novel transgenic mouse strain (Cldn2-EGFP) (Gong et al., 2003) to investigate how the tight junction protein claudin-2 becomes zonated in hepatocytes during liver maturation and after CCl 4 -induced acute injury. We also used conditional deletion approaches and Cldn2-EGFP mice to investigate the role of hepatic sinusoid-derived Wnt ligands in the establishment and maintenance of liver zonation, and the role of endothelial-derived Wnt ligands in zonation restoration after CCl 4 -induced damage.
Results
Spatiotemporal analysis of postnatal liver zonation using Cldn2-EGFP transgenic mice
Published studies showed that the tight junction protein claudin-2 exhibits zonated expression in perivenous areas of the adult murine liver (Matsumoto et al., 2014; Rahner et al., 2001) . Using immunohistochemistry analysis, we corroborated claudin-2 expression almost exclusively in perivenous areas in the adult mouse liver ( Figure 1A) . In addition, we discovered that this protein is expressed throughout this organ of mice at postnatal [P] day 2 ( Figure 1A) . To further examine how claudin-2 hepatic expression transitions from birth to adulthood, we took advantage of Cldn2-EGFP mice that express a green fluorescence protein (GFP) transgene under the control of Cldn2 regulatory elements (Gong et al., 2003) . Our immunostaining results showed identical distribution of claudin-2 and GFP in various tissues of wildtype and Cldn2-EGFP mice dissected at P2 or 6 months of age (including the liver [ Figure 1A . Also, double-immunofluorescence staining of 1-6 months old Cldn2-EGFP livers showed co-expression of GFP with various hepatocyte markers (i.e., HNF4a, Tbx3 and Prox1; Figure 1B) , the Zone 3 marker GS ( Figure 1B ) and the Zone 2/3 marker Cyp2e1 ( Figure 1B) . In contrast, GFP expression was very low or negligible in periportal hepatocytes expressing the cell adhesion protein and Zone 1 marker E-cadherin ( Figure 1B) . These results demonstrate that GFP expression faithfully recapitulates the endogenous expression of claudin-2 in many tissues of Cldn2-EGFP mice.
Next, we compared the spatiotemporal distribution of GFP with that of other zonated proteins in the liver of Cldn2-EGFP mice harvested at different ages using double-immunofluorescence analysis. As previously shown (Burke et al., 2018; Notenboom et al., 1997) , GS was expressed exclusively in the first 2-3 layers of hepatocytes surrounding the central veins at E18.5 ( Figure 1C ) and this restricted expression pattern remained unchanged at P2, P15 and P30 ( Figure 1C) . Similarly, Cyp2e1 expression was confined to a large area of pericentral/perivenous hepatocytes from E18.5 to adulthood ( Figure 1C ). Different to those proteins, claudin-2/GFP expression was not detected in hepatocytes at E18.5 ( Figure 1C) whereas that protein was broadly expressed in hepatocytes at P2 ( Figure 1C and Figure 1-figure supplement 2B) . The wide distribution of claudin-2/GFP in hepatocytes was transient since this protein was largely confined to pericentral (GS + ) and perivenous (Cyp2e1 + ) hepatocytes at both P15 and P30 ( Figure 1C,D) . On the other hand, we uncovered that E-cadherin was expressed in all hepatocytes at both E18.5 and P2 ( Figure 1C ; Figure 1 -figure supplement 2) and was restricted to periportal hepatocytes at P15 and P30 ( Figure 1C ). Those findings concur with a published study (Rocha et al., 2015) showing that E-cadherin is not fully zonated in the murine liver at P10. Similar to E-cadherin, the periportal enzyme phosphoenolpyruvate carboxykinase (PEPCK) was broadly expressed at birth (P0) and was restricted to Zone one by P11 (Figure 1-figure supplement 3A) , and this transition coincided with induction of the Wnt/b-catenin inhibitor APC (Benhamouche et al., 2006) in periportal hepatocytes (Figure 1-figure supplement 3C). In conclusion, our study uncovered a dynamic, non-synchronous spatiotemporal segregation of metabolic and membrane-associated hepatocyte functions in the maturing liver. Figure 1 . Claudin-2 expression becomes zonated during liver maturation. (A) Immunohistochemistry analysis of claudin-2 and claudin-2/GFP expression showing identical distribution of these proteins in hepatocytes (arrows) at P2 and P30. Few hepatocytes near the portal veins (arrowheads) also express low claudin-2 or claudin-2/GFP at P30. Wildtype specimens were used for claudin-2 analysis and Cldn2-EGFP specimens for claudin-2/GFP analysis. Scale bars: 50 mm (right); and 100 mm (left). (B) Double-immunofluorescence analysis showing co-expression of claudin-2/GFP (arrows) with the hepatocyte transcription factors HNF4a, Tbx3 and Prox1 around the central veins in P30 Cldn2-EGFP livers. Scale bars: 100 mm. (C) Double-immunofluorescence results show lack of claudin-2/GFP hepatic expression late in gestation (E18.5), numerous claudin-2/GFP + hepatocytes (arrows) distributed throughout the liver after birth (P2), and high claudin-2/GFP expression (arrows) restricted to Zone 3 (GS + ) and Zone 2/3 (Cyp2e1 + ) hepatocytes in juvenile (P15) and adult (P30) livers (a few pericentral/perivenous hepatocytes [arrowheads] do not express GFP at P30). E-cadherin expression (yellow arrows) is detected in all hepatocytes at E18.5 and P2, and is restricted to periportal hepatocytes that lack high claudin-2/GFP expression at P15-P30. Scale bars: 200 mm (E18.5, P2, P15) and 100 mm (P30). (D) Quantification of GS + , Cyp2e1 + and claudin-2/GFP + areas and the relative abundance of claudin-2/GFP + hepatocytes in Zone 2 in postnatal (P2), juvenile (P15) and adult (P30) livers. 3-4 representative fields from three individual livers of each genotype were used for quantification. Statistical difference was determined by one-way ANOVA with Bonferroni's multiple comparisons test. NS, not significant (p>0.05), *p<0.05, ***p<0.001. Source data 1. Quantification of GS+, Cyp2e1+ and claudin-2/GFP+ areas and the relative abundance of claudin-2/GFP+ hepatocytes in Zone two in P2, P15 and P30 livers. Endothelial-secreted Wnt ligands maintain claudin-2 zonated expression in the adult liver Wnt/b-catenin signaling is a key regulator of metabolic zonation (Benhamouche et al., 2006; Burke et al., 2009; Planas-Paz et al., 2016; Sekine et al., 2006; Yang et al., 2014) and recent studies demonstrated that hepatic endothelial cells (HECs) produce Wnt ligands and agonists that preserve homeostatic metabolic zonation in the adult liver (Leibing et al., 2018; Planas-Paz et al., 2016; Preziosi et al., 2018; Rocha et al., 2015; Wang et al., 2015) . We observed that most claudin-2/GFP + hepatocytes juxtaposed HECs in the liver of Cldn2-EGFP newborn and adult mice ( Figure 2A ) and this result suggested to us that claudin-2 zonated expression requires endothelial Wnt signaling. To investigate this possibility, we deleted the Wls gene (encoding a protein necessary for Wnt exocytosis) (Carpenter et al., 2010) in murine ECs using conditional-deletion approaches. Adult wildtype (control) mice, Cldn2-EGFP (control) mice, Cdh5-CreERT2;Wls f/f (Wang et al., 2010 ) (Wls-deleted) mice, and Cdh5-CreERT2;Wls f/f ;Cldn2-EGFP (Wls-deleted) mice were injected with tamoxifen and their liver was harvested and processed for immunostaining 2 weeks later ( Figure 2B ). Tamoxifen treatment did not affect GS, Cyp2e1 or E-cadherin expression in wildtype livers ( Figure 2C ), or claudin-2/GFP expression in Cldn2-EGFP livers ( Figure 2C and data not shown). In contrast, Wls endothelial deletion eliminated GS pericentral expression almost entirely ( Figure Figure 2D and data not shown). These results demonstrate that endothelial Wnt signaling preserves metabolic and non-metabolic zonation in the adult murine liver.
LSEC Wnt ligand secretion is dispensable to initially establish hepatic zonation and is necessary to maintain adult hepatic zonation Murine HECs are heterogeneous (Halpern et al., 2018) and include both central vein endothelial cells (CEVs) and liver sinusoidal endothelial cells (LSECs). CEVs and LSECs express CD31/PECAM-1 whereas LSECs uniquely express the lymphatic marker Lyve-1 (Halpern et al., 2018; Mouta Carreira et al., 2001) . Also, recent studies showed that CEVs express Wnt2 and Wnt9b ligands and the Wnt agonist R-spondin 3 (Rspo3) and LSECs express Wnt2 ligands in the homeostatic adult mouse liver (Ding et al., 2010; Halpern et al., 2018; Preziosi et al., 2018; Rocha et al., 2015; Wang et al., 2015; Zhao et al., 2019) . Similar to those findings, we detected Wnt2, Wnt9b and Rspo3 transcripts in cells lining the central veins in adult (P60) and newborn (P2) mouse livers ( Figure 3A) . We also uncovered that LSECs adjacent or close to the central veins expressed Wnt2, Wnt9b and Rspo3 in P2 livers ( Figure 3A) whereas LSECs located more distal to the central veins expressed Wnt2 in P60 livers ( Figure 3A and Figure 3 -figure supplement 1). Additional results of immunofluorescence analysis showed that most GS + hepatocytes in Zone 3 and most Cyp2e1 + hepatocytes in Zone 2/3 adjoined LSECs in the liver of newborn (P2), juvenile (P15) and adult (P30) mice ( Figure 3B) . Similarly, most claudin-2/GFP + hepatocytes were contiguous to LSECs in Cldn2-EGFP livers at P2, P15 and P30 ( Figure 3B ). These findings posited that Zone 2/3 hepatocyte expression requires Wnt ligands secreted from LSECs. To test this notion, we deleted Wls in LSECs of Cldn2-EGFP mice using Lyve1-Cre mice (Pham et al., 2010) .
First, we performed lineage tracing experiments in Lyve1-Cre;ROSA-LacZ mice and found that LSECs (Lyve1 + ) expressed the b-galactosidase reporter protein and CEVs (PECAM + /Lyve1 -) lacked that protein (Figure 3-figure supplement 2). These results demonstrated that Wnt ligand secretion should be preserved in CEVs and abolished in LSECs using Lyve1-Cre. Next, we produced Lyve1-Cre;Cldn2-EGFP mice (control) and Lyve1-Cre;Wls f/f ;Cldn2-EGFP mice (Wls-deficient) and analyzed their liver using immunofluorescence, morphometry and immunohistochemistry analyses. We uncovered slightly reduced abundance of GS + hepatocytes and normal abundance of Cyp2e1 + , claudin-2/ GFP + and E-cadherin + hepatocytes ( Figure 3C ) in Lyve1-Cre;Wls f/f ;Cldn2-EGFP livers compared to control livers at P2. In contrast, GS expression was almost undetected and the areas of Cyp2e1 and claudin-2/GFP expression were significantly reduced and restricted to a few layers of pericentral hepatocytes in Lyve1-Cre;Wls f/f ;Cldn2-EGFP adult (P30) livers in comparison to control livers ( Figure 3C ). Identical alterations in GS, Cyp2e1 and claudin-2 hepatocyte expression were also noticed in the liver of Lyve1-Cre;Wls f/f adult mice ( Figure 3-figure supplement 3) . Interestingly, Wls deletion in LSECs also affected E-cadherin expression since we observed ectopic expression of this protein in pericentral and perivenous hepatocytes in Lyve1-Cre;Wls f/f ;Cldn2-EGFP adult livers ( Figure 3C) . Results from qRT-PCR experiments confirmed significant decreases in pericentral/perivenous transcripts (i.e., Glul, Cyp2e1, Axin2, Cldn2 and Tbx3), and significant upregulation of the periportal transcripts Apc and Cdh1 ( Figure 3D ) in P30 Lyve1-Cre;Wls f/f livers. In summary, we determined that Wnt ligand secretion from LSECs is dispensable or redundant for the initiation of hepatic zonation, and is necessary to maintain metabolic and non-metabolic zonation in the adult liver. (C) P2, Quantitative double immunofluorescence results show that Zone 2 (Cyp2e1 + , claudin-2/GFP + ) is relatively unchanged and Zone 3 (GS + ) is significantly reduced in Lyve1-Cre;Wls f/f ;Cldn2-GFP livers at P2. E-cadherin expression (arrows) is indistinguishable in P2 livers with or without endothelial Wls-deletion. P30, Similar quantitative results demonstrate that GS + hepatocytes are nearly absent, Zone 2 (Cyp2e1 + /GFP + ) is significantly reduced and restricted to pericentral areas, and E-cadherin expression (arrows, arrowheads are GFP + hepatocytes) is expanded towards the central veins in P30 Lyve1-Cre;Wls f/f ;Cldn2-GFP livers. 3-4 representative fields from three individual livers of each genotype were used for quantification. p values were determined by two-tailed unpaired Student's t-test, NS, not significant (p>0.05), *p<0.05, ***p<0.001. Arrows indicate GFP-double positive hepatocytes, white arrowheads are GFP + hepatocytes and yellow arrowheads are GFPhepatocytes. Scale bars: 100 mm (D) Q-PCR results demonstrate reduced expression of Zone 2/3 transcripts, increased expression of Zone 1 transcripts, and normal levels of the hepatocyte transcript Prox1, in adult Lyve1-Cre;Wls f/f livers (n = 3). p values were determined by two-way ANOVA, NS, not significant (p>0.05), *p<0.05, ***p<0.001. (E) Q-PCR results showing the effects of culturing AML-12 mouse hepatic cells with CHIR99021, Wnt2, Wntb9, or Wnt2/Wnt9b plus Rspo3 on Axin2, Cyp2e1, Glul and Cldn2 expression. p values from two-tailed unpaired Student's t-test, *p<0.05, ***p<0.01; n = 6. (A-C) Asterisks indicate central vein lumens. Related data can be found in To further examine the effects of Wnt/b-catenin stimulation on claudin-2 hepatocyte expression, we cultured the murine hepatocyte-derived cell line AML12 (Lehwald et al., 2011) in the presence of CHIR99021 (a GSK-3 inhibitor that promotes nuclear b-catenin accumulation (Gerbal-Chaloin et al., 2014) , Wnt2, Wnt9b, or Wnt2/Wnt9b and Rspo3. QRT-PCR results showed significantly increased expression of the Wnt/bÀcatenin target Axin2 in AML12 cells incubated with CHIR99021, Wnt2+Rspo3 or Wnt9b+Rspo3 ( Figure 3E) . Similarly, CHIR99021, Wnt2 and Wnt9b increased Cyp2e1 expression in those cells and the addition of Rspo3 further enhanced the effect of Wnt2/Wnt9b ( Figure 3E ). On the other hand, although CHIR99021 stimulated Glul and Cldn2 expression by 2-3-fold ( Figure 3E ) the presence of Wnt2/Wnt9b alone or in combination with Rspo3 did not increase those transcripts (in fact, Wnt2 marginally reduced their levels; Figure 3E ). The reason(s) behind the distinct responses of Cyp2e1, Glul and Cldn2 to Wnt signaling are unclear but could involve variable thresholds for Wnt stimulation, synergy of Wnt/b-catenin signaling with other pathways, and/or differences in cellular composition between AML-12 cells and intact hepatocytes.
Zones 3 and 2 are reestablished differently in the regenerating liver after acute injury
In rodents administered a CCl 4 bolus, the cytochrome P450 enzyme Cyp2e1 metabolizes this compound into highly reactive free radicals that cause cellular damage and necrosis of Zone 2/3 hepatocytes. This process is followed by a regenerative phase encompassing hepatocyte mass recovery, restoration of zonated patterns, and remodeling of the entire organ's architecture (Tanaka and Miyajima, 2016) . In spite of the extensive literature on the effects of CCl 4 , our knowledge about the reestablishment of hepatic zonation following acute or chronic exposure to CCl 4 is still limited and most publications in this topic did not examine parenchymal and non-parenchymal cell behaviors simultaneously (Font-Burgada et al., 2015; Pu et al., 2016; Zhao et al., 2019) . Furthermore, we do not know if claudin-2 expression is affected following acute CCl 4 exposure or how the expression of this protein is restored in the injury model. To address those issues, we injected Cldn2-EGFP mice with CCl 4 and analyzed their liver 2-7 days post-injection ( Figure 4A ). Quantification of ALT/AST serum levels validated the occurrence of liver damage at day two and functional recovery of this organ at day 7 ( Figure 4B ) after a CCl 4 bolus.
To examine changes in zonation patterns downstream of CCl 4 acute exposure, we stained Cldn2-EGFP livers with anti-GS (Zone 3), anti-Cyp2e1 (Zone 2/3), anti-E-cadherin (Zone 1), anti-GFP (claudin-2 + hepatocytes), and anti-Tbx3 (Zone 2/3) antibodies. In comparison to control livers, ( Figure 4C ) most hepatocytes in Zone 3 (GS + ) looked enucleated and necrotic and only 1-2 layers of normal-looking nucleated Cyp2e1 + /GFP + hepatocytes remained in Zone 2 ( Figure 4D ) 2 days post-CCl 4 injection. On the other hand, a few nucleated GS + hepatocytes reappeared at the margins of an enlarged Cyp2e1 + /GFP + area and their number increased 3-5 days post-CCl 4 administration ( Figure 4D ). Finally, the areas of GS, Cyp2e1 and claudin-2/GFP expression looked nearly restored 7 days after the initial CCl 4 bolus ( Figure 4D ). The analysis of temporal patterns of tissue damage and zonation recovery in the liver of wildtype mice injected with CCl 4 showed identical results (including claudin-2 expression; Figure 4 -figure supplement 1).
Our analysis revealed that E-cadherin hepatic expression also changes upon CCl 4 exposure since Zone 2/3 GFP + hepatocytes did not express this protein in control livers ( Figure 4C ) and most GFP + hepatocytes expressed E-cadherin 2-5 days after CCl 4 injection ( Figure 4D) . Thus, in the CCl 4acutely injured liver E-cadherin expression transiently expands into Zone two during the 'injury phase' and then retracts to its original periportal (Zone 1) domain during the 'repair phase'. Finally, since Tbx3 and claudin-2/GFP proteins colocalize extensively in the uninjured adult liver ( Figures 1C  and 4C ) we compared their expression in the Cldn2-EGFP injured liver and uncovered broad overlap of Tbx3 and GFP immunoreactivity throughout the course of recovery (i.e., 2-7 days post-CCl 4 ; Figure 4C ). More interesting, we observed that GFPperiportal hepatocytes transiently expressed low-to-moderate levels of Tbx3 2-5 days post-CCl 4 injection ( Figure 4C ). This result argues that periportal hepatocytes also respond to local cues during the 'repair phase' that follows CCl 4 -induced injury.
To further investigate how Zone 2/3 (Cyp2e1 + ) hepatocytes recover in the CCl 4 -injured liver, we injected wildtype mice with ethynyldeoxyuridine (EdU) 2 days after the initial CCl 4 bolus and sacrificed the animals 2 hr or 5 days (i.e., 120 hr) later. Results of quantitative immunofluorescence analysis showed incorporation of EdU in the surviving Cyp2e1 + hepatocytes after a 2 hr chase ( Figure 4F ) and persistent EdU labeling in the expanded Zone 2 (Cyp2e1 + ) after a 5 day chase ( Figure 4F ). In addition, we detected EdU incorporation in Ecad + /Cyp2e1periportal hepatocytes after a 2 hr or 5 day chase ( Figure 4F ). This result was intriguing because a recent study (Font-Burgada et al., 2015) showed restoration of hepatocyte mass from Sox9 + periportal hepatocytes in a mouse model of chronic liver damage. Therefore, we investigated if Sox9 + -hepatocytes contribute to restore metabolic zonation in the CCl 4 -injured liver by injecting Sox9 CreER ;ROSA-EGFP mice with tamoxifen and then CCl 4 and harvesting the liver 7 days later (Figure 4-figure supplement 2A) . Results of immunostaining showed expression of the GFP lineage-tracer in a few periportal hepatocytes and no GFP expression in Cyp2e1 + hepatocytes (Figure 4-figure supplement 2B) in the CCl 4 -injured Sox9 CreER ;ROSA-EGFP liver. This finding ruled out the contribution of Sox9 + periportal hepatocytes to metabolic Zone 2/3 restoration after CCl 4 -acute damage. Instead, our results indicate that in this injury model metabolic Zone 2 is recovered via proliferation of undamaged hepatocytes and metabolic Zone 3 is induced de novo.
To complement our analysis of Cldn2-GFP livers exposed to CCl 4 , we investigated the composition of the immune infiltrates in tissues harvested 2-7 days after CCl 4 injection ( Figure 5A ) using double-immunofluorescence and antibodies recognizing the pan-macrophage marker F4/80, the M1 macrophage marker CD86, and the M2 macrophage marker CD206 (Shapouri-Moghaddam et al., 2018) . This analysis showed that most macrophages in Cldn2-GFP control livers were parenchymal Kupffer cells since they expressed F4/80 ( Figure 5B ) but not CD86 ( Figure 5C ) or CD206 (data not shown). On the other hand, in CCl 4 -injected Cldn2-GFP livers most macrophages infiltrating the central veins represented M1 macrophages that expressed F4/80 and CD86 ( Figure 5B ,C) but not CD206 ( Figure 5D and data not shown). Quantitative results demonstrated that the average abundance of perivenous macrophages increased at around day three post-CCl 4 and began to decline afterwards ( Figure 5E ). Also, most CD86 + macrophages concentrated around the central veins in CCl 4 -injected livers ( Figure 5C ) although in periportal areas of this organ a few isolated CD86 + cells were also found within the hepatic sinusoids ( Figure 5F ). This finding argues that perhaps some periportal CD86 + macrophages travel through the sinusoids towards pericentral areas in the CCl 4 -damaged liver.
Endothelial Wnts reestablish claudin-2 zonated expression in hepatocytes following CCl 4 -induced acute injury HECs produce Wnts and other factors that stimulate liver growth (Ding et al., 2010; Hu et al., 2014; Leibing et al., 2018; Preziosi et al., 2018; Zhao et al., 2019) and Wnt ligands that help to repair the architecture of the CCl 4 -injured liver (Zhao et al., 2019) . Our finding that most claudin2-GFP + hepatocytes were contiguous to HECs (PECAM-1 + ) during the recovery period that follows a CCl 4 bolus ( Figure 6A ) posited that Wnt secretion from HECs help reestablishing metabolic and non-metabolic zonation in this injury model. To test this notion, we administered CCl 4 to Cdh5-CreERT2 (control) and Cdh5-CreERT2;Wls f/f mice at day 0, injected three consecutive daily doses of tamoxifen, and harvested the livers 2-15 days post CCl 4 injection. We uncovered similar increases in circulating ALT/AST levels at day 2 and numerous macrophage infiltrates in hepatic perivenous areas at day 5 in Cdh5-CreERT2 and Cdh5-CreERT2;Wls f/f mice ( Figure 6B) . These results validated the occurrence of hepatic damage in both mouse strains. Similar to our previous findings in Cldn2-EGFP mice (Figure 2) , Zones 3 (GS + ) and 2 (Cyp2e1 + ) looked almost recovered at day 7 and these areas were completely restored at day 15 in the Cdh5-CreERT2 liver. In contrast, Zone 3 was nearly absent and Zone 2 was significantly reduced in Cdh5-CreERT2;Wls f/f livers at days 5, 7 and 15 post-CCl 4 administration ( Figure 6B) . Also, E-cadherin expression retracted to its normal location in periportal Zone 1 in Cdh5-CreERT2 livers 7-15 days post-CCl 4 injection whereas E-cadherin expression was ectopically expanded into perivenous areas in CCl 4 -injured Cdh5-CreERT2;Wls f/f livers dissected at similar time points ( Figure 6B) . These results demonstrate that endothelial Wnt secretion is necessary to reestablish Zone 3, to recover the normal size of Zone 2, and to restore E-cadherin expression to Zone 1 hepatocytes, in CCl 4 -acutely injured livers.
HECs are heterogeneous and similar to hepatocytes these cells display zonated distribution of various proteins. For instance, recent studies in adult mouse livers showed that central vein endothelial cells express Wnt2, Wnt9b and Rspo3 transcripts whereas perivenous sinusoidal cells express Wnt2 transcripts (Halpern et al., 2018; Zhao et al., 2019) . Also, Kit transcripts (encoding the surface marker CD117) are abundant in HECs located close to the CV and low or absent in HECs located in periportal areas of the adult liver (Halpern et al., 2018) . Using immunostaining analysis, we uncovered that the hepatic sinusoids traversing Zones 2 and 3 express CD117 but not those located in periportal liver areas of the adult mouse liver ( Figure 6C) . Also, in those tissues the CD117 + sinusoidal cells located in pericentral areas expressed very low levels of Lyve-1 ( Figure 6C ). This expression pattern was almost identical in the CCl 4 -injected liver (at day 3) although in the injured organ the LSECs within Zone 2 (Cyp2e1 + ) showed more extensive colocalization of CD117 and Lyve-1 compared to the uninjured liver ( Figure 6C ). Since CD117 is expressed more abundantly in percentral/ perivenous LSECs than in periportal LSECs, we attempted to isolate these 2 cell populations using CD117-coated magnetic beads and then investigate their Wnt/Rspo expression profile under normal and acute injury conditions. For the 'injury' experiment, LSECs were isolated from mouse livers 3 days after a CCl 4 bolus because at this time point we observed de novo induction of GS expression, expansion of Zone 2 (Cyp2e1 + /claudin-2 + ) and perivenous and periportal hepatocyte proliferation (Figure 4) . Also, for these experiments we included an initial purification step with anti-CD31 antibodies to remove potential contamination of CD117 + immune cells in the injured liver ( Figure 6D) . The results of qRT-PCR analysis showed relatively similar Lyve1 expression between CD117 + /CD31 + cells ('pericentral/perivenous LSECs') and Lyve-1 + /CD31 + cells ('periportal LSECs'; Figure 6E ). Also, this analysis showed relatively higher Kit expression in CD117 + /CD31 + cells compared to Lyve-1 + / CD31 + cells in both the homeostatic and injured liver. On the other hand, Kit expression was lower in LSECs from CCl 4 -injured livers compared to LSECs from control livers ( Figure 6E) and this result likely indicates that many perivenous LSECs were lost due to extensive tissue damage. Interestingly, the LSECs isolated from CCl 4 -injured livers expressed higher levels of Wnt2, Wnt9b and Rspo3 compared to LSECs from control livers, and this difference was more prominent in the CD117 + /CD31 + LSEC fraction ( Figure 6E) . This result was surprising since Rspo3 and Wnt9b transcripts are mainly expressed in pericentral LSECs in the uninjured liver ( Figure 3A and Zhao et al., 2019) . Therefore, we postulate that Wnt ligands and Wnt agonists are broadly upregulated in LSECs upon acute liver injury.
Lyve1-cre;Wls f/f mice are refractory to CCl 4 -induced liver damage
As we found that the expanding claudin2-GFP + area continuously juxtaposed LSECs (Lyve-1 + ) in Cldn2-GFP livers exposed to CCl 4 ( Figure 7A ) and pericentral/perivenous LSECs express Wnt ligands in the CCl 4 -acutely injured liver ( Figure 6E) , we investigated whether Wls deletion from LSECs affects zonation restoration in the CCl 4 -injury model. We used Lyve1-Cre;Wls f/f mice for these experiments because we predicted that the remaining Cyp2e1 + hepatocytes ( Figure 7B) should be susceptible to CCl 4 -induced toxicity. CCl 4 administration to Lyve1-Cre (control) mice led to extensive Zone 2 damage, loss of Zone 3 and elevated ALT/AST serum levels 2 days post injection ( Figure 7C) , extensive perivenous macrophage infiltration at day 4 ( Figure 7D) , and almost complete restoration of tissue architecture and metabolic zonation at day 7 ( Figure 7E) . Surprisingly, CCl 4 administration to Lyve1-Cre;Wls f/f mice did not produce any obvious changes in tissue architecture or zonated marker distribution in comparison to Lyve1-Cre;Wls f/f mice injected with saline ( Figure 7B-E; Figure 7-figure supplement 1) . Furthermore, Lyve1-Cre;Wls f/f mice injected with CCl 4 had normal ALT/AST serum levels at day 2 ( Figure 7C) and did not show perivenous macrophage infiltrates at day 4 ( Figure 7D ). We also injected Cdh5-CreERT2;Wls f/f mice first with tamoxifen (to delete Wls) and 2 weeks later with CCl 4 (to induce Zone 2/3 hepatotoxicity) and then harvested their liver 3 days later. Similar to Lyve1-Cre;Wls f/f mice, in Cdh5-CreERT2;Wls f/f livers administered a CCl 4 bolus we did detect macrophage infiltrates (Figure 7-figure supplement 2B) or observed features indicative of liver damage (Figure 7-figure supplement 2A) . Thus, we conclude that the remaining Cyp2e1 + hepatocytes in Lyve1-Cre;Wls f/f livers are protected or refractory to CCl 4 -induced toxicity.
Discussion
The concept of Liver Zonation was proposed almost 40 years ago to explain the spatial separation of metabolic functions in the adult liver (Jungermann and Katz, 1989) . Subsequent breakthroughs were the identification of Wnt/b-catenin signaling as a key regulator of metabolic hepatic zonation (Benhamouche et al., 2006; Burke et al., 2009; Burke et al., 2018; Planas-Paz et al., 2016; Sekine et al., 2006; Yang et al., 2014) and the discovery that HECs are a major source of Wnt ligands in the adult liver (Leibing et al., 2018; Planas-Paz et al., 2016; Preziosi et al., 2018; Rocha et al., 2015; Wang et al., 2015) . Our study extends those findings by showing that similar regulatory mechanisms control metabolic and non-metabolic zonation in the liver. Specifically, we demonstrate that: 1) endothelial Wnt signaling restricts the expression of a tight junction protein (claudin-2) and the expression of a cell adhesion protein (E-cadherin) to complementary regions in the adult liver; 2) the restoration of metabolic and non-metabolic zonation after CCl 4 -acute injury requires Wnt ligands produced by endothelial cells; and 3) the secretion of Wnt ligands from hepatic sinusoidal cells is dispensable or redundant for the establishment of metabolic and non-metabolic zonation in the newborn liver, and is necessary to preserve zonation patterns in the adult liver.
Our study also introduces a novel transgenic mouse model (Cldn2-EGFP) suitable to investigate changes in claudin-2 expression during development, regeneration and disease. Using those mice, we discovered a unique distribution of claudin-2 proteins in hepatocytes relative to other membrane proteins and enzymes both at birth and in adulthood. Claudin-2 function is necessary for proper bile flow and bile composition (Matsumoto et al., 2014; Yeh et al., 2010) and the spatiotemporal changes that we uncovered probably reflect how the maturing liver adapts to new metabolic demands and stressors. We also obtained evidence that the mechanism(s) that initiate claudin-2 expression in immature hepatocytes and the mechanism(s) that preserve claudin-2 expression in mature hepatocytes are different. Specifically, we found that Wnt ligand secretion from the hepatic sinusoidal endothelium is necessary to maintain claudin-2 expression in adult hepatocytes and dispensable for the onset of claudin-2 expression in newborn hepatocytes. Our discovery that Wnt/bcatenin signaling regulates claudin-2 expression in mature hepatocytes concurs with a published study showing that b-catenin deletion in adult hepatocytes causes significant downregulation of claudin-2 proteins (Yeh et al., 2010) . Investigating how claudin-2 expression is regulated in hepatic cells has clinical relevance because deficiency of this protein causes intrahepatic cholestasis and increases gall stone formation in mice (Matsumoto et al., 2014; Yeh et al., 2010) . To further investigate the effects of Wnt signaling on claudin-2 expression, we performed experiments in the hepatocytederived cell line AML-12. Surprisingly, the addition of Wnt2 or Wnt9b alone or in combination with Rspo3 had no demonstrable effect on Cldn2 expression whereas those same factors stimulated the expression of Axin2 (a known Wnt/b-catenin target gene) in AML-12 cells. Possible explanations for those unanticipated results include differences in the cellular context of immortalized AML-12 cells compared to intact hepatocytes, or the requirement of distinct Wnt thresholds and/or specific Wnt ligand combinations to stimulate Axin2 vs. Cldn2 hepatocyte expression.
Another interesting finding in our study is that preserving metabolic and non-metabolic zonation in the adult liver requires Wnt ligand secretion from LSECs. Using the same Lyve1-Cre mouse strain that we used here, other researchers produced Lyve1-Cre;Wls f/f mice and similar to us they described that GS and Cyp2e1 proteins were absent or barely detected in the mutant adult liver (Preziosi et al., 2018) . On the other hand, that study did not examine alterations in other zonated proteins in the mutant adult liver or the phenotype of Lyve1-Cre;Wls f/f newborn livers. Furthermore, those authors concluded that Wls was deleted in both CEVs and LSECs in Lyve1-Cre;Wls f/f livers. In contrast, our results of lineage tracing experiments invalidated that cre recombinase was ever expressed in CEVs in our Lyve1-Cre;Wls f/f mice. Whether differences in the genetic background of the mice used in the two studies explain the discrepant results is unclear. On the other hand, our discovery that GS and Cyp2e1 protein expression was relatively normal in the Lyve1-Cre;Wls f/f newborn liver indicates that other cellular sources of Wnts (most probably CEVs) and not LSECs initiate metabolic zonation. Moreover, our results from in situ hybridization experiments and qRT-PCR analysis of isolated LSECs (CD117 + /CD31 + and Lyve-1 + /CD31 + /CD117 LOW ) support a model in which CEVs produce Wnt ligands and agonists (most likely Wnt2, Wnt9b and Rspo3) that induce metabolic Zones 2/ 3 in the perinatal liver, and LSECs secrete Wnt ligands (mainly Wnt2) that preserve metabolic and non-metabolic zonation in the adult liver. Overall, our results support and expand other published data (Ding et al., 2010; Wang et al., 2015; Zhao et al., 2019) .
We also took advantage of Cldn2-EGFP mice to analyze simultaneously parenchymal and nonparenchymal cell behaviors in the CCl 4 -acute injury mouse model. Our analysis revealed several interesting new findings in this model, including a small population of intact Cyp2e1 + /GFP + hepatocytes that remained located at the margins of the area of necrosis. Why some Cyp2e1 + hepatocytes survive the injurious insult is not known, but one possibility is that the dose of CCl 4 is too low to access all Zone 2 hepatocytes. On the other hand, some results in our study indicated that the remaining Cyp2e1 + hepatocytes and the surrounding Cyp2e1hepatocytes repaired the damaged Zone 2 through proliferation: 1) those cells expressed the regulator of hepatic progenitor proliferation Tbx3 [(Lüdtke et al., 2009 ; 2) both Cyp2e1 + hepatocytes and Cyp2e1hepatocytes incorporated EdU in their DNA and retained this label for up to 5 days. This notion is favored by the results of recent studies showing that liver repair mainly occurs via proliferation of perivenous and periportal hepatocytes in different mouse models of liver injury (including the CCl 4 model described here) (Chen et al., 2020; Matsumoto et al., 2020; Sun et al., 2020) . Interestingly, we found that in contrast to Cyp2e1 + /GFP + hepatocytes all hepatocytes in pericentral Zone 3 (GS + /GFP + ) were destroyed upon CCl 4 acute exposure and in the next 1-2 days GS expression was induced de novo in a few GFP + hepatocytes located at the front of Zone 2. The number of GS + /GFP + hepatocytes subsequently increased and those cells gradually adjoined the central vein endothelium as the immune infiltrates resolved. These results demonstrate that Zone 3 is specified de novo at the front of an expanding Zone 2 during the repair process that follows CCl 4 -acute liver injury. Similar observations were reported in a recent study in which Axin2 + hepatocytes were genetically ablated and the authors showed complete destruction of Zone 3 and subsequent reappearance of GS + hepatocytes in areas juxtaposed to the CV endothelium (Sun et al., 2020) . We hypothesize that Wnt ligands and Wnt agonists produced by intact LSECs are major players in the induction of a new Zone 3 in the CCl 4 -injury model because the new GS + cells were always juxtaposed or near the liver sinusoidal endothelium and, conversely, those cells were physically separated from the central vein endothelium by macrophage infiltrates. Whether a specialized subset of LSECs produces the Wnt ligands and agonists that repair Zones 2 and 3 remains an open question although our results of immunofluorescence and magnetic bead purification experiments suggested that CD117 + /Lyve-1 + LSECs are major sources of Wnt2, Wnt9b and Rspo3 during the repair process that follows CCl 4induced injury.
In summary, our study complements and expands current knowledge on liver zonation and regeneration by showing that multiple Wnt endothelial sources help to orchestrate the spatiotemporal distribution of hepatocyte functions during liver maturation and to promote metabolic zone respecification during liver repair. The advantages we encountered using Cldn2-GFP mice advocate their use in similar investigations of parenchymal and non-parenchymal cell behavior in chronic liver damage or conditions that lead to pathologic claudin-2 expression. 
Materials and methods

Animal experiments
For adult Wls endothelial deletion, Cdh5-CreERT2;Wls loxP/loxP mice and Cdh5-CreERT2 littermates (4-6 weeks old) received one intraperitoneal (i.p.) tamoxifen injection (250 mg/kg) for three consecutive days, and used for further experiments after a 2 week wash out period. For acute liver injury induction, an i.p. bolus of 1 mL/g body weight CCl 4 (Sigma, 319961, St. Louis, MO) diluted 4x in corn oil (Sigma, C8267, St. Louis, MO) was administered. For EdU labeling, mice first received an i.p. CCl 4 bolus (1 mL/g body weight) and 2 days later they were injected (i.p.) with EdU (50 mg/g body weight; Invitrogen A10044, Waltham, MA). For lineage tracing experiments using Sox9-CreERT2; ROSA26-EGFP mice, the animals first received an i.p. CCl 4 bolus (1 mL/g body weight) and for the next 3 days they received one daily intraperitoneal (i.p.) tamoxifen injection (250 mg/kg). Blood was collected from the retro-orbital plexus and coagulated at room temperature for 1 hr. Adult mice used in this study were age-and gender-matched littermates. The animal experiments are not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.
Morphometric analysis
Images were taken at 10x magnification for Zone 1 (Ecad + ) and Zone 2/3 (Cyp2e1 + /claudin-2/GFP + ), and 20x for Zone 3 (GS + ). Areas for quantification were selected using Photoshop CC 2015 and were measured using Image J software. Edu + hepatocytes were counted using ImageJ. Triplicate samples were used and at least three different areas were selected per sample for quantification.
In situ hybridization
Livers were isolated from newborn (P2) or adult mice, cut in slices and fixed in 4% PFA at 4˚C overnight. After embedding in paraffin, 7 mm sections were cut, deparaffinized in xylene, rehydrated in ethanol, and processed for RNA in situ hybridization using the RNAScope 2.5 HD Duplex Kit following the manufacturer's instructions (Advanced Cell Diagnostics Hepatic endothelial cell (HEC) isolation with magnetic beads Before HECs isolation, 2 mg of each rat anti-CD31(BD Pharmigen, cat. 550274), rat anti-CD117 (R and D Systems, cat. MAB1356) and rat anti-Lyve-1 (R and D systems, cat. MAB215) antibodies were incubated with 25 ml of magnetic beads (Dynabeads Sheep Anti-Rat IgG, Invitrogen, cat.11035) 1 hr at 4˚C. A Dynamag-15 Magnet (Invitrogen, cat.12301D) was used to isolate the antibody conjugated-beads as per the manufacturer's recommendation. HECs were isolated from mice injected with CCl 4 or saline and sacrificed 3 days later. The liver was perfused through the inferior vena cava first with 20 mL perfusion medium I (1X PBS, 10 mM HEPES, 0.5 g/L KCl, 50 mM glucose, 0.2 mM EDTA, pH 7.4) at 37˚C, followed by 50 mL perfusion medium II (1X PBS, 30 mM HEPES, 0.5 g/L KCl, 50 mM glucose, 1 mM CaCl 2 , 0.5 mg/mL Collagenase H, pH 7.4) at 37˚C. Upon dissecting the liver, the cells were dispersed in cold DMEM medium and passed through a 100 mm strainer. The nonparenchymal cells (NPCs) were separated from hepatocytes by low-speed centrifugation (50 x g, 5 min) at 4˚C. The supernatant containing NPCs was collected and washed twice at 50 x g for 5 min at 4˚C, and pelleted at 170 x g for 10 min. The cell pellets were resuspended in 1 mL red cell lysis buffer (155 mM NH 4 Cl, 12 mM NaHCO 3 , 0.1 mM EDTA) and incubated for 1 min at room temperature (RT), followed by addition of 10 mL isolation buffer (1X PBS Ca 2+ and Mg 2+ free, 0.1% BSA, 2 mM EDTA, pH 7.4). 1 Â 10 7 NPCs were resuspended in 1 mL isolaton buffer and incubated with 25 mL of anti-CD31 Dynabeads for 30 min at 4˚C, After the tube was placed in the magnet for 1 min, the supernatant was discarded, the magnetic beads were washed twice with isolation buffer and the CD31 + cells were incubated with release buffer [Dynabeads FlowComp Mouse CD4, Invitrogen, 11461D] 10 min at RT, eluted and incubated with 25 mL of anti-CD117 Dynabeads for 30 min at 4˚C. After Dynabead binding, the CD117 + /CD31 + fraction was isolated as indicated above and lysed in TRIzol (1 mL) for RNA isolation. The unbound supernatant was incubated with anti-Lyve-1 Dynabeads and the Lyve1 + /CD31 + /CD117 low cells were isolated as previously indicated.
Statistics and quantitative analysis
The data represent the mean ± SEM and P value were calculated by two-tailed unpaired Student's ttest ( Figures 2E, 3C , D, 4F and 6E) or one-way ANOVA ( Figures 1D, 4E , 5E, 6B and 7C) or twoway ANOVA ( Figures 3E, F and 4B) by the GraphPad Prism 8.0 software. NS, not significant (p>0.05), *p<0.05, **p<0.01, ***p<0.001. Each quantitative experiment was repeated at least three times. We considered biological replicates as those animals or tissues subjected to the same experimental test, and technical replicates as individual samples or tissues subjected to the same analysis.
Study approval
All animal experiments were performed in accordance with protocols reviewed and approved by the Institutional Animal Care and Use Committee at Northwestern University. The animal welfare assurance number for this study is A3283-01.
